Lab Reagents
Human IgG antibody Laboratories manufactures the triponan test (sp) reagents distributed by Genprice. The Triponan Test (Sp) reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact troponin assay. Other Triponan products are available in stock. Specificity: Triponan Category: Test Group: (Sp)
(Sp) information
SP 141 |
|
C4120-10 |
ApexBio |
10 mg |
EUR 270 |
|
Description: SP 141 is a specific, potent and selective small-molecule antagonist of MDM2 with Ki value of 28±6 nM. Mouse double minute 2 protein (Mdm2) is an ubiquitin ligase that promotes p53 degradation, a tumor suppressor that controls a major pathway protecting cells from malignant transformation [1]. |
SP 141 |
|
C4120-5 |
ApexBio |
5 mg |
EUR 183 |
|
Description: SP 141 is a specific, potent and selective small-molecule antagonist of MDM2 with Ki value of 28±6 nM. Mouse double minute 2 protein (Mdm2) is an ubiquitin ligase that promotes p53 degradation, a tumor suppressor that controls a major pathway protecting cells from malignant transformation [1]. |
SP 141 |
|
C4120-50 |
ApexBio |
50 mg |
EUR 1024 |
|
Description: SP 141 is a specific, potent and selective small-molecule antagonist of MDM2 with Ki value of 28±6 nM. Mouse double minute 2 protein (Mdm2) is an ubiquitin ligase that promotes p53 degradation, a tumor suppressor that controls a major pathway protecting cells from malignant transformation [1]. |
2B-(SP) |
|
B5180-1 |
ApexBio |
1 mg |
EUR 405 |
SP 600125 |
|
A4604-10 |
ApexBio |
10 mg |
EUR 108 |
|
Description: SP600125 is a selective, reversible and ATP-competitive inhibitor of Jun N-terminal kinase (JNK) with IC50 values of 40, 40 and 90 nM for JNK1, 2 and 3, respectively [1].SP600125 was screened out from a time-resolved f luorescence assay using the GST-c-Jun and recombinant human JNK2. |
SP 600125 |
|
A4604-100 |
ApexBio |
100 mg |
EUR 148 |
|
Description: SP600125 is a selective, reversible and ATP-competitive inhibitor of Jun N-terminal kinase (JNK) with IC50 values of 40, 40 and 90 nM for JNK1, 2 and 3, respectively [1].SP600125 was screened out from a time-resolved f luorescence assay using the GST-c-Jun and recombinant human JNK2. |
SP 600125 |
|
A4604-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
|
Description: SP600125 is a selective, reversible and ATP-competitive inhibitor of Jun N-terminal kinase (JNK) with IC50 values of 40, 40 and 90 nM for JNK1, 2 and 3, respectively [1].SP600125 was screened out from a time-resolved f luorescence assay using the GST-c-Jun and recombinant human JNK2. |
SP 600125 |
|
A4604-50 |
ApexBio |
50 mg |
EUR 125 |
|
Description: SP600125 is a selective, reversible and ATP-competitive inhibitor of Jun N-terminal kinase (JNK) with IC50 values of 40, 40 and 90 nM for JNK1, 2 and 3, respectively [1].SP600125 was screened out from a time-resolved f luorescence assay using the GST-c-Jun and recombinant human JNK2. |
SP 600125 |
|
A4604-500 |
ApexBio |
500 mg |
EUR 444 |
|
Description: SP600125 is a selective, reversible and ATP-competitive inhibitor of Jun N-terminal kinase (JNK) with IC50 values of 40, 40 and 90 nM for JNK1, 2 and 3, respectively [1].SP600125 was screened out from a time-resolved f luorescence assay using the GST-c-Jun and recombinant human JNK2. |
SP 600125 |
|
A4604-S |
ApexBio |
Evaluation Sample |
EUR 81 |
|
Description: SP600125 is a selective, reversible and ATP-competitive inhibitor of Jun N-terminal kinase (JNK) with IC50 values of 40, 40 and 90 nM for JNK1, 2 and 3, respectively [1].SP600125 was screened out from a time-resolved f luorescence assay using the GST-c-Jun and recombinant human JNK2. |
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
|
GEN-402-25tests |
All test |
25 tests |
EUR 244 |
|
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
